About Us

Supriya Lifescience Limited headquartered in Mumbai, India is a public listed generic pharmaceutical company established in 1987 dedicated to developing, commercializing APIs & FDFs to treat patients with various diseases and infections. The API facility located at Lote, Maharashtra, India is multiple times USFDA, EDQM/EUGMP approved, and Health Canada approved.

Area of Focus








& above CAGR since 2019


Employee Strength

We have a global footprint that extends across 86 countries


Latest News

13 Feb 2024

Supriya Life Science ના પરિણામ પર કંપનીના Director Saloni Wagh સાથે ચર્ચા

Watch Now

12 Feb 2024

Supriya Life Science के Q3 Results, नए प्रोडक्ट लॉन्च और कारोबार पर MD Dr. Satish Wagh का Outlook

Watch Now

12 Feb 2024

Q3 Was Good Because Of Growth In Sales In Europe

Watch Now

08 Feb 2024

Supriya Lifesciences Q3 Results: Net profit triples to Rs 30 crore

Read More

11 Jan 2024

Supriya Lifesciences targets Brazil, eyes Rs 200 crore sales in 2-3 years

Watch Now

09 Jan 2024

Supriya Lifescience gets GMP certification from ANVISA Brazil

Read More

08 Jan 2024

Supriya Lifescience eyes strong growth in Latin America with 10 newly registered APIs

Read More

Several awards for excellence and outstanding performance.

Established in the year 1987, Supriya Lifescience Ltd. is a global leading manufacturer of Active pharmaceutical Ingredients. Our state-of-the-art facility is certified by USFDA, EDQM, EUGMP, NMPA & Health Canada. Facility is located in Khed, District Ratnagiri and headquartered in Mumbai, India.

Read More